QIAGEN powered by
How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability

QIAGEN Digital Insights Monday, April 25, 2022

The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into the trove…

Digging for rare finds – two breast cancer publications to keep a watch for in V95

QIAGEN Digital Insights Tuesday, February 1, 2022

While the world showed its support for affected people during Breast Cancer Awareness Month, COSMIC’s expert curators were working hard…

Looking ahead to AMP 2015

QIAGEN Digital Insights Tuesday, November 3, 2015

Austin, here we come!  We’re getting AMPed up for the upcoming Association for Molecular Pathology 2015 annual meeting! Held at…